Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,475 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation.
Sipeky C, Llerena A, Manolopoulos VG, Pearson E, Mlakar V, Gozzo L, Simmaco M, Marchetti P, Re MD, Stankovic S, Meyer U, Cascorbi I, Ingelman-Sundberg M, Suarez-Kurtz G, Marc J, Katsila T, Paulmichl M, Nofziger C, Ansari M, Drago F, van Schaik RH. Sipeky C, et al. Among authors: marchetti p. Pharmacogenomics. 2019 Oct;20(15):1063-1069. doi: 10.2217/pgs-2019-0095. Pharmacogenomics. 2019. PMID: 31588876
H2020 and Beyond: Skip Discrepancy between Theory and Practice of Personalized Medicine. A Position Paper by the Italian Society of Personalized Medicine.
Borro M, Simmaco M, Aceti A, Barni S, De Luca A, Fineschi V, Frati P, Girardi P, Miozzo M, Nati G, Nicoletti F, Santini D, Marchetti P. Borro M, et al. Among authors: marchetti p. Curr Pharm Biotechnol. 2016;17(10):926-9. doi: 10.2174/1389201017666160519112850. Curr Pharm Biotechnol. 2016. PMID: 27194357
A nomogram to predict 5-fluorouracil toxicity: when pharmacogenomics meets the patient.
Botticelli A, Onesti CE, Strigari L, Occhipinti M, Di Pietro FR, Cerbelli B, Petremolo A, Anselmi E, Macrini S, Roberto M, Falcone R, Lionetto L, Borro M, Milano A, Gentile G, Simmaco M, Marchetti P, Mazzuca F. Botticelli A, et al. Among authors: marchetti p. Anticancer Drugs. 2017 Jun;28(5):551-556. doi: 10.1097/CAD.0000000000000492. Anticancer Drugs. 2017. PMID: 28296649
Individualized Drugs' Selection by Evaluation of Drug Properties, Pharmacogenomics and Clinical Parameters: Performance of a Bioinformatic Tool Compared to a Clinically Established Counselling Process.
Borro M, Gentile G, Preissner SH, Pomes LM, Gohlke BO, Del Casale A, Eckert A, Marchetti P, Preissner S, Preissner R, Simmaco M. Borro M, et al. Among authors: marchetti p. Pharmgenomics Pers Med. 2021 Aug 5;14:955-962. doi: 10.2147/PGPM.S316556. eCollection 2021. Pharmgenomics Pers Med. 2021. PMID: 34385834 Free PMC article.
Pre-treatment evaluation of 5-fluorouracil degradation rate: association of poor and ultra-rapid metabolism with severe toxicity in a colorectal cancer patients cohort.
Mazzuca F, Borro M, Botticelli A, Mazzotti E, Marchetti L, Gentile G, La Torre M, Lionetto L, Simmaco M, Marchetti P. Mazzuca F, et al. Among authors: marchetti p, marchetti l. Oncotarget. 2016 Apr 12;7(15):20612-20. doi: 10.18632/oncotarget.7991. Oncotarget. 2016. PMID: 26967565 Free PMC article.
1,475 results